Becton, Dickinson & Co. (BDX)
187.52
+0.40
(+0.21%)
USD |
NYSE |
Sep 02, 16:00
187.52
0.00 (0.00%)
Pre-Market: 20:00
Becton, Dickinson Research and Development Expense (TTM) : 1.135B for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.135B |
| March 31, 2026 | 1.107B |
| December 31, 2025 | 1.09B |
| September 30, 2025 | 1.127B |
| June 30, 2025 | 1.107B |
| March 31, 2025 | 1.176B |
| December 31, 2024 | 1.243B |
| September 30, 2024 | 1.19B |
| June 30, 2024 | 1.169B |
| March 31, 2024 | 1.176B |
| December 31, 2023 | 1.214B |
| September 30, 2023 | 1.237B |
| June 30, 2023 | 1.256B |
| March 31, 2023 | 1.265B |
| December 31, 2022 | 1.271B |
| September 30, 2022 | 1.272B |
| June 30, 2022 | 1.34B |
| March 31, 2022 | 1.355B |
| December 31, 2021 | 1.329B |
| September 30, 2021 | 1.306B |
| June 30, 2021 | 1.237B |
| March 31, 2021 | 1.169B |
| December 31, 2020 | 1.116B |
| September 30, 2020 | 1.095B |
| June 30, 2020 | 1.066B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.086B |
| December 31, 2019 | 1.074B |
| September 30, 2019 | 1.062B |
| June 30, 2019 | 1.069B |
| March 31, 2019 | 1.064B |
| December 31, 2018 | 1.071B |
| September 30, 2018 | 1.005B |
| June 30, 2018 | 949.00M |
| March 31, 2018 | 858.00M |
| December 31, 2017 | 786.00M |
| September 30, 2017 | 776.00M |
| June 30, 2017 | 808.00M |
| March 31, 2017 | 829.00M |
| December 31, 2016 | 824.00M |
| September 30, 2016 | 829.00M |
| June 30, 2016 | 772.00M |
| March 31, 2016 | 743.00M |
| December 31, 2015 | 690.00M |
| September 30, 2015 | 632.00M |
| June 30, 2015 | 570.00M |
| March 31, 2015 | 520.00M |
| December 31, 2014 | 518.00M |
| September 30, 2014 | 515.00M |
| June 30, 2014 | 513.35M |
| March 31, 2014 | 506.46M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Abbott Laboratories | 3.128B |
| Boston Scientific Corp. | 2.153B |
| Stryker Corp. | 1.606B |
| Baxter International, Inc. | 480.00M |
| Intuitive Surgical, Inc. | 1.414B |